Bryologyx
Coming May 24

Lessons Learned From Over 50 Medical and Pharmaceutical Investments

Date & Time


May 24, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event


For the past 36 years, Dr. John Abeles has either been investing in or founding pharmaceutical and
medical companies. During that time, he’s learned a thing or two.

Join us for a fireside chat as Dr. Abeles and Bryologyx CEO, Thomas Loarie, share their best practices in
healthcare investing and talk about their latest endeavor, Bryologyx, Inc.

BryoLogyx is developing a platform of antigen stimulating drugs that make tumors more “visible” to
therapeutics by increasing the expression of cell surface antigens. This makes current therapies more
effective.

Join our webinar to hear from these experienced leaders and why they consider Bryologyx to be a
crucial platform for the future of Immunology.

Register


SHARE THIS EVENT
Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.